SCHEMBL31632272

SCHEMBL31632272

N#Cc1ccc(-c2cc(=O)c3cc(Cl)c(N)c(N)c3o2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 3/20 0.53
▸ AR P10275 2/20 0.44
▸ TERT O14746 1/20 0.44
▸ EGFR P00533 1/20 0.42
▸ SRC P12931 1/20 0.42
▸ CSNK2A2 P19784 3/20 0.40
▸ CSNK2B P67870 3/20 0.40
▸ CSNK2A1 P68400 3/20 0.40
▸ CYP1A2 P05177 4/20 0.40
▸ CYP1B1 Q16678 4/20 0.40
▸ CYP1A1 P04798 3/20 0.40
▸ PRKDC P78527 2/20 0.40
▸ GABRP O00591 1/20 0.39
▸ GABRD O14764 1/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ GABRB1 P18505 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39
▸ GABRA3 P34903 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31632255 0.85 TNKS (0.46) TNKSARTERTCSNK2A2CSNK2B
SCHEMBL31632287 0.85 TNKS (0.53) TNKSAREGFRSRCCSNK2A2
SCHEMBL31632387 0.85 TNKS (0.53) TNKSARTERTEGFRSRC
SCHEMBL31632370 0.82 TNKS (0.56) TNKSARTERTEGFRSRC
SCHEMBL31632312 0.79 AR (0.50) TNKSARTERTEGFRCSNK2A2
SCHEMBL31632431 0.76 TNKS (0.47) TNKSARTERTCSNK2A2CSNK2B
SCHEMBL21801263 0.74 CSNK2A2 (0.52) TNKSARTERTCSNK2A2CSNK2B
SCHEMBL24046894 0.74 TNKS (0.56) TNKSARCSNK2A2CSNK2BCSNK2A1
SCHEMBL31632321 0.73 AR (0.46) TNKSARCSNK2A2CSNK2BCSNK2A1
SCHEMBL31632396 0.72 AR (0.43) TNKSARTERTCSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025125811-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Ontrack Therapeutics Limited (GB) 2025-06-19 — — WO disclosed
Send feedback